Jundishapur Journal of Microbiology

Published by: Kowsar

The incidence of Drug- Resistant Mutants in Patients With Chronic HBV Infection After Lamivudine Treatment

Sepide Ezzatpanah Fard 1 , 2 , Zohreh Sharifi 1 , * , Seyed Masoud Hosseini 2 and Mahmood Mahmoodian Shooshtari 1
Authors Information
1 Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, IR Iran
2 Department of Microbiology, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
Article information
  • Jundishapur Journal of Microbiology: October 01, 2013, 6 (8); e7366
  • Published Online: October 1, 2013
  • Article Type: Research Article
  • Received: July 22, 2012
  • Revised: October 29, 2012
  • Accepted: December 8, 2012
  • DOI: 10.5812/jjm.7366

To Cite: Ezzatpanah Fard S, Sharifi Z, Hosseini S M, Mahmoodian Shooshtari M. The incidence of Drug- Resistant Mutants in Patients With Chronic HBV Infection After Lamivudine Treatment, Jundishapur J Microbiol. 2013 ; 6(8):e7366. doi: 10.5812/jjm.7366.

Abstract
Copyright © 2013, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Chan K, Yam I, Yuen J, Yuen MF, Lai CL, Alexander GJ, et al. A comprehensive HBV array for the detection of HBV mutants and genotype. Clin Biochem. 2011; 44(14-15): 1253-60[DOI][PubMed]
  • 2. Ma Y, Ding Y, Juan F, Dou XG. Genotyping the hepatitis B virus with a fragment of the HBV DNA polymerase gene in Shenyang, China. Virol J. 2011; 8: 315[DOI][PubMed]
  • 3. Levinson Warren, Jawetz Ernest. Medical microbiology and immunology. 2001; : 403-41
  • 4. Blitz L, Pujol FH, Swenson PD, Porto L, Atencio R, Araujo M, et al. Antigenic diversity of hepatitis B virus strains of genotype F in Amerindians and other population groups from Venezuela. J Clin Microbiol. 1998; 36(3): 648-51[PubMed]
  • 5. Orito E, Ichida T, Sakugawa H, Sata M, Horiike N, Hino K, et al. Geographic distribution of hepatitis B virus (HBV) genotype in patients with chronic HBV infection in Japan. Hepatology. 2001; 34(3): 590-4[DOI][PubMed]
  • 6. Zhu R, Zhang HP, Yu H, Li H, Ling YQ, Hu XQ, et al. Hepatitis B virus mutations associated with in situ expression of hepatitis B core antigen, viral load and prognosis in chronic hepatitis B patients. Pathol Res Pract. 2008; 204(10): 731-42[DOI][PubMed]
  • 7. Furusyo N, Nakashima H, Kashiwagi K, Kubo N, Hayashida K, Usuda S, et al. Clinical outcomes of hepatitis B virus (HBV) genotypes B and C in Japanese patients with chronic HBV infection. Am J Trop Med Hyg. 2002; 67(2): 151-7[PubMed]
  • 8. Sallam TA, William Tong CY. African links and hepatitis B virus genotypes in the Republic of Yemen. J Med Virol. 2004; 73(1): 23-8[DOI][PubMed]
  • 9. Okamoto H, Tsuda F, Sakugawa H, Sastrosoewignjo RI, Imai M, Miyakawa Y, et al. Typing hepatitis B virus by homology in nucleotide sequence: comparison of surface antigen subtypes. J Gen Virol. 1988; 69 ( Pt 10): 2575-83[PubMed]
  • 10. Sharifi Z, Yari F, Gharebaghiyan A. Sequence analysis of the polymerase gene in hepatitis B virus infected blood donors in Iran. Arch Iran Med. 2012; 15(2): 88-90[PubMed]
  • 11. Zali Mohammad Reza. Hepatitis B resistance in Iran. Gastroenterol Hepatol Bed Bench. 2010; 3(2)
  • 12. Locarnini S, Zoulim F. Molecular genetics of HBV infection. Antivir Ther. 2010; 15 Suppl 3: 3-14[DOI][PubMed]
  • 13. Robinson SW. Hepatitis B Virus. 1990;
  • 14. Keeffe EB, Dieterich DT, Pawlotsky JM, Benhamou Y. Chronic hepatitis B: preventing, detecting, and managing viral resistance. Clin Gastroenterol Hepatol. 2008; 6(3): 268-74[DOI][PubMed]
  • 15. Chen CH, Lee CM, Tung WC, Wang JH, Hung CH, Hu TH, et al. Evolution of full-length HBV sequences in chronic hepatitis B patients with sequential lamivudine and adefovir dipivoxil resistance. J Hepatol. 2010; 52(4): 478-85[DOI][PubMed]
  • 16. Vincenti D, Solmone M, Garbuglia AR, Iacomi F, Capobianchi MR. A sensitive direct sequencing assay based on nested PCR for the detection of HBV polymerase and surface glycoprotein mutations. J Virol Methods. 2009; 159(1): 53-7[DOI][PubMed]
  • 17. Ghany MG, Doo EC. Antiviral resistance and hepatitis B therapy. Hepatology. 2009; 49(5 Suppl)-84[DOI][PubMed]
  • 18. Liaw YF, Chien RN, Yeh CT, Tsai SL, Chu CM. Acute exacerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during lamivudine therapy. Hepatology. 1999; 30(2): 567-72[DOI][PubMed]
  • 19. Tipples GA, Ma MM, Fischer KP, Bain VG, Kneteman NM, Tyrrell DL. Mutation in HBV RNA-dependent DNA polymerase confers resistance to lamivudine in vivo. Hepatology. 1996; 24(3): 714-7[DOI][PubMed]
  • 20. Leung NW, Lai CL, Chang TT, Guan R, Lee CM, Ng KY, et al. Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: results after 3 years of therapy. Hepatology. 2001; 33(6): 1527-32[DOI][PubMed]
  • 21. Liaw YF, Sung JJ, Chow WC, Farrell G, Lee CZ, Yuen H, et al. Lamivudine for patients with chronic hepatitis B and advanced liver disease. N Engl J Med. 2004; 351(15): 1521-31[DOI][PubMed]
  • 22. Ghandehari F, Pourazar A, Zadeh MS, Tajedin N. Probing rate of YMDD motif mutant in lamivudine treatment of Iranian patients with chronic hepatitis B virus infection. Asian J Transfus Sci. 2011; 5(1): 32-4[DOI][PubMed]
  • 23. Li D, Gu HX, Zhang SY, Zhong ZH, Zhuang M, Hattori T. YMDD mutations and genotypes of hepatitis B virus in northern China. Jpn J Infect Dis. 2006; 59(1): 42-5[PubMed]
  • 24. Ramezani A, Velayati AA, Roshan MR, Gachkar L, Banifazl M, Keyvani H, et al. Rate of YMDD motif mutants in lamivudine-untreated Iranian patients with chronic hepatitis B virus infection. Int J Infect Dis. 2008; 12(3): 252-5[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments